SCHEMBL5366200

SCHEMBL5366200

O=C1Nc2c(Br)cc(Br)cc2C1=Cc1ccc(C(=O)O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
METAP1 P53582 1/20 0.56
PIM1 P11309 2/20 0.55
MAPT P10636 1/20 0.49
CSNK2A2 P19784 3/20 0.44
CSNK2B P67870 3/20 0.44
CSNK2A1 P68400 3/20 0.44
CSNK2A3 Q8NEV1 3/20 0.44
PLK4 O00444 1/20 0.43
RAF1 P04049 3/20 0.43
SIRT1 Q96EB6 2/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42
MAP1LC3B Q9GZQ8 1/20 0.42
MYC P01106 1/20 0.41
IL1RN P18510 1/20 0.41
ERAP1 Q9NZ08 1/20 0.41
EGFR P00533 1/20 0.41
PDGFRB P09619 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5361431 0.87 METAP1 (0.54) MEN1KMT2AMETAP1MAPTPLK4
SCHEMBL5365589 0.86 KMT2A (0.51) MEN1KMT2APIM1PLK4RAF1
SCHEMBL5358437 0.85 LRRK2 (0.49) MEN1KMT2APLK4RAF1SIRT1
SCHEMBL7136615 0.83 SIRT2 (0.52) MEN1KMT2APIM1PLK4RAF1
SCHEMBL5361680 0.83 SIRT2 (0.54) MEN1KMT2AMETAP1PIM1PLK4
SCHEMBL7137520 0.83 ALDH1A1 (0.48) MEN1KMT2APIM1MAPTPLK4
SCHEMBL7136821 0.83 LRRK2 (0.51) MEN1KMT2APLK4SIRT1SIRT2
SCHEMBL7137447 0.81 LRRK2 (0.59) MEN1KMT2APIM1CSNK2A1PLK4
SCHEMBL7136985 0.80 NTRK1 (0.54) MEN1KMT2APLK4RAF1SIRT1
SCHEMBL5361621 0.80 MEN1 (0.43) MEN1KMT2AMAPTPLK4SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK MEN1 3855/4885KMT2A 4060/4885METAP1 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.